[HTML][HTML] Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid …
N Santoro, M Labopin, F Giannotti, G Ehninger… - Journal of hematology & …, 2018 - Springer
Background Acute myeloid leukemia (AML) is both more common and with more biologically
aggressive phenotype in the elderly. Allogenic stem cell transplantation (allo-SCT) is the …
aggressive phenotype in the elderly. Allogenic stem cell transplantation (allo-SCT) is the …
[HTML][HTML] HLA-matched sibling versus unrelated versus haploidentical related donor allogeneic hematopoietic stem cell transplantation for patients aged over 60 years …
R Devillier, F Legrand, J Rey, L Castagna… - Biology of Blood and …, 2018 - Elsevier
Haploidentical related donor (HRD) allogeneic hematopoietic stem cell transplantation (allo-
HSCT) was developed as a valid option for the treatment of acute myeloid leukemia (AML) in …
HSCT) was developed as a valid option for the treatment of acute myeloid leukemia (AML) in …
Comparison of haploidentical hematopoietic stem cell transplantation with chemotherapy in older adults with acute myeloid leukemia
YQ Sun, XH Zhang, Q Jiang, H Jiang… - Bone Marrow …, 2023 - nature.com
Acute myeloid leukemia (AML) outcomes are very poor in older patients. Haploidentical
stem cell transplantation (haplo-SCT) helps to achieve long-term survival. However, the …
stem cell transplantation (haplo-SCT) helps to achieve long-term survival. However, the …
[HTML][HTML] Comparable outcomes after alternative and matched sibling donor hematopoietic stem cell transplantation and the role of molecular measurable residual …
BS Cho, SA Yahng, GJ Min, S Park, SS Park… - … and Cellular Therapy, 2021 - Elsevier
Allogeneic hematopoietic stem cell transplantation (HSCT) remains the most effective
postremission therapy conferring the chance of cure for acute myeloid leukemia (AML) …
postremission therapy conferring the chance of cure for acute myeloid leukemia (AML) …
[HTML][HTML] The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in …
MT Rubio, BN Savani, M Labopin, E Polge… - Journal of hematology & …, 2016 - Springer
Background Data comparing fully matched and mismatched-unrelated-donor (M-and mM-
URD) allogeneic hematopoietic stem cell transplant (allo-SCT) following reduced intensity …
URD) allogeneic hematopoietic stem cell transplant (allo-SCT) following reduced intensity …
Impact of donor age on allogeneic hematopoietic cell transplantation outcomes in older adults with acute myeloid leukemia
MB Abid, N Estrada-Merly, MJ Zhang, K Chen… - … and Cellular Therapy, 2023 - Elsevier
Allogeneic hematopoietic cell transplantation (alloHCT) provides cure for older patients with
acute myeloid leukemia (AML); however, disease relapse remains a major concern. Based …
acute myeloid leukemia (AML); however, disease relapse remains a major concern. Based …
Haploidentical related donor vs matched sibling donor allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome …
J Huang, F Huang, Z Fan, N Xu, L Xuan, H Liu… - Cancer …, 2020 - Wiley Online Library
Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is a potentially curative
therapeutic option for patients with acute myeloid leukemia (AML) or myelodysplastic …
therapeutic option for patients with acute myeloid leukemia (AML) or myelodysplastic …
Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and over
N Santoro, M Labopin, F Ciceri, MT Van Lint, D Nasso… - Cancer, 2019 - Wiley Online Library
Background T cell–replete haploidentical stem cell transplantation (haplo‐SCT) is a valid
therapeutic option for adult patients with high‐risk acute myeloid leukemia (AML) lacking an …
therapeutic option for adult patients with high‐risk acute myeloid leukemia (AML) lacking an …
[HTML][HTML] Haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide and peripheral blood stem cell grafts in older adults with acute myeloid …
M Slade, JF DiPersio, P Westervelt, R Vij… - Biology of Blood and …, 2017 - Elsevier
Many hematologic malignancies are diseases of aging, and the use of hematopoietic cell
transplant (HCT) is growing rapidly among older adults. Modern post-transplant …
transplant (HCT) is growing rapidly among older adults. Modern post-transplant …
Current status and perspectives of allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia
As in younger patients, allogeneic stem cell transplantation (alloHSCT) offers the best
chance for durable remission in older patients (≥ 60 years) with acute myeloid leukemia …
chance for durable remission in older patients (≥ 60 years) with acute myeloid leukemia …